GEHCGE HealthCare

Health care · Medical Imaging · Nasdaq

Employees: 54,000
Headquarters: Chicago, IL
CEO: Peter J. Arduini
Next results: around Feb 3, 2027

RevenueFY2021–25 $20.6B+4.8% Highest in 5 years 10-K FY2025 · XBRL Net incomeFY2021–25 $2.1B+4.6% FY2024: $2.0B 10-K FY2025 · XBRL Free cash flowFY2021–25 $1.5B−3.2% FY2024: $1.6B 10-K FY2025 · XBRL Operating marginFY2021–25 13.4%+0.1 pts 15.9% in FY2021 10-K FY2025 · XBRL

What changed

10-K filed Feb 4, 2026 against Feb 13, 2025

Area	What changed	Source
Risk factors	9 new paragraphs, nothing like them in the previous 10-K	10-K Item 1A
Cash from operations lower than net income	Cash from operations $2.0B vs net income $2.1B (FY ending 2025-12-31)	10-K · XBRL
Inventory growing faster than revenue	Inventory +15.2% vs revenue +4.8% (+10.4 pts)	10-K · XBRL
Accounting checks	8 other checks clear, 2 worth a look	10-K · XBRL
Insiders	No open-market buys in the last 90 days	Form 4
Filings	3 in the last 30 days	EDGAR

Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.

What's new, in their words

10-K filed Feb 4, 2026

Paragraphs in Risk Factors that were not in the 10-K filed 2025-02-13. Quoted as filed.

This summary of risks is intended to provide an overview of the principal risks we face and should not be considered a substitute for a review of the more detailed risk factors discussed immediately following this summary. •Our business is subject to the effects of global geopolitical and economic instability and public health crises.
10-K, Item 1A

All 9 new paragraphs →

Accounting checks

latest 10-K

8 of 10 clear 2 worth a look. Checks, not verdicts.

!
Cash from operations lower than net incomeCash from operations $2.0B vs net income $2.1B (FY ending 2025-12-31)
!
Inventory growing faster than revenueInventory +15.2% vs revenue +4.8% (+10.4 pts)
✓
Same auditor in both 10-Ks: Deloitte & Touche LLP
✓
No statement of substantial doubt about going concern
✓
No 8-K item 4.02 in the last 2 years
✓
No NT 10-K or NT 10-Q in the last 2 years
✓
No longer listed: Income Taxes - Valuation Allowance on Deferred Tax Assets
✓
No sentence in the 10-K concludes that controls were not effective because of a material weakness
✓
No 8-K item 2.06 in the last 2 years
✓
No 8-K item 1.03 in the last 2 years

How each check works, with sources →

In the last 30 days

All filings →

Nov 5, 20268-K Director or officer change 8-K item 5.02
Oct 28, 2026Officer CEO change On October 22, 2026, Jeannette Bankes notified GE HealthCare that she will resign as President and CEO, Patient Care Solutions.
Oct 28, 202610-Q Quarterly report (10-Q) period ended Sep 30, 2026

Get an email when this changes: new risk paragraphs, accounting items, insider purchases, a new 10-K or 10-Q. RSS feed

Work on GEHC in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/GEHC/export.csv") into a cell.